Legato Capital Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-98,229
| Closed | -$102K | – | 579 |
|
|
2024
Q3 | $102K | Hold |
98,229
| – | – | 0.01% | 537 |
|
|
2024
Q2 | $170K | Hold |
98,229
| – | – | 0.02% | 524 |
|
|
2024
Q1 | $235K | Hold |
98,229
| – | – | 0.03% | 526 |
|
|
2023
Q4 | $327K | Hold |
98,229
| – | – | 0.04% | 484 |
|
|
2023
Q3 | $367K | Buy |
98,229
+39,191
| +66% | +$147K | 0.05% | 460 |
|
|
2023
Q2 | $252K | Hold |
59,038
| – | – | 0.03% | 496 |
|
|
2023
Q1 | $404K | Hold |
59,038
| – | – | 0.07% | 386 |
|
|
2022
Q4 | $468K | Buy |
+59,038
| New | +$468K | 0.09% | 358 |
|